Trametinib With GSK2141795 in BRAF Wild-type Melanoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified February 2015 by Adil Daud, University of California, San Francisco.
Recruitment status was: Active, not recruiting

Sponsor:

ClinicalTrials.gov Identifier:

NCT01941927

First Posted: September 13, 2013

Last Update Posted: February 19, 2015

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborator:

National Comprehensive Cancer Network

Information provided by (Responsible Party):

Adil Daud, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2016
Primary Completion Date:	December 2014 (Final data collection date for primary outcome measure)

To Top